Iovance grants inducement stock options for 179,750 shares at $10.02 each
IOVA•Inducement stock options granted to new employees
Iovance Biotherapeutics granted inducement stock options covering 179,750 shares to 18 new, non-executive employees on Sept. 17, 2026.
Options carry an exercise price of $10.02, set at the stock’s closing price on the grant date.
Vesting runs over three years, with one-third on the first anniversary of the start date. The remaining shares vest in eight quarterly installments over the following two years, contingent on continued employment.
